New heart valve device shows promise in early trial

NCT ID NCT06680427

Ongoing Disease control Sponsor: MiRus Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 29 times

Summary

This study tests a new device called the Siegel TAVR for people with severe aortic stenosis, a condition where the heart's aortic valve is narrowed. The goal is to see if the device is safe and can be implanted successfully in 30 adults aged 50 and older. The device is placed without open-heart surgery, using a thin tube through a blood vessel.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS SYMPTOMATIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Atlantic Health System

Morristown, New Jersey, 07960, United States
Cedars-Sinai Medical Center

Los Angeles, California, 90071, United States
Cleveland Clinic

Cleveland, Ohio, 44195, United States
Columbia University Medical Center/ NYPH

New York, New York, 10032, United States
Mayo Clinic

Rochester, Minnesota, 55905, United States
NCH Healthcare System

Naples, Florida, 34102, United States
Piedmont Healthcare

Atlanta, Georgia, 30309, United States
Stanford

Palo Alto, California, 94304, United States

Conditions

Explore the condition pages connected to this study.

AORTIC STENOSIS SYMPTOMATIC